Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2018, Article ID 8592532, 11 pages
https://doi.org/10.1155/2018/8592532
Research Article

Whole-Body Cryotherapy Decreases the Levels of Inflammatory, Oxidative Stress, and Atherosclerosis Plaque Markers in Male Patients with Active-Phase Ankylosing Spondylitis in the Absence of Classical Cardiovascular Risk Factors

1School of Medicine with the Division of Dentistry in Zabrze, Department of Internal Medicine, Angiology and Physical Medicine, Medical University of Silesia, Batorego Street 15, 41-902 Bytom, Poland
2Department of Medical Physics, Chełkowski Institute of Physics, University of Silesia, 4 Uniwersytecka St., 40-007 Katowice, Poland
3School of Medicine with the Division of Dentistry in Zabrze, Department of Biochemistry, Medical University of Silesia, Jordana 19 St., 41-808 Zabrze, Poland

Correspondence should be addressed to Agata Stanek; lp.nelt@kenatsa

Received 26 August 2017; Accepted 19 October 2017; Published 1 February 2018

Academic Editor: Adrian Doroszko

Copyright © 2018 Agata Stanek et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Bremander, I. F. Petersson, S. Bergman, and M. Englund, “Population-based estimates of common comorbidities and cardiovascular disease in ankylosing spondylitis,” Arthritis Care & Research, vol. 63, no. 4, pp. 550–556, 2011. View at Publisher · View at Google Scholar
  2. N. Bodnar, G. Kerekes, I. Seres et al., “Assessment of subclinical vascular disease associated with ankylosing spondylitis,” The Journal of Rheumatology, vol. 38, no. 4, pp. 723–729, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Stanek, A. Cholewka, T. Wielkoszyński, E. Romuk, K. Sieroń, and A. Sieroń, “Increased levels of oxidative stress markers, soluble CD40 Ligand and carotid intima-media thickness reflect acceleration of atherosclerosis in male patients with ankylosing spondylitis in active phase and without the classical cardiovascular risk factors,” Oxidative Medicine and Cellular Longevity, vol. 2017, Article ID 9712536, 8 pages, 2017. View at Publisher · View at Google Scholar
  4. D. van der Heijde, S. Ramiro, R. Landewé et al., “2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis,” Annals of the Rheumatic Diseases, vol. 76, no. 6, pp. 978–991, 2017. View at Publisher · View at Google Scholar · View at Scopus
  5. L. A. Passalent, “Physiotherapy for ankylosing spondylitis: evidence and application,” Current Opinion in Rheumatology, vol. 23, no. 2, pp. 142–147, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Tyrrell, W. Schmidt, D. H. Williams, and C. H. Redshaw, “Physical activity in ankylosing spondylitis: evaluation and analysis of an eHealth tool,” Journal of Innovation in Health Informatics, vol. 23, no. 2, pp. 510–522, 2016. View at Publisher · View at Google Scholar · View at Scopus
  7. X. Guillot, N. Tordi, L. Mourot et al., “Cryotherapy in inflammatory rheumatic diseases: a systematic review,” Expert Review of Clinical Immunology, vol. 10, no. 2, pp. 281–294, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. G. Lombardi, E. Ziemann, and G. Banfi, “Whole-body cryotherapy in athletes: from therapy to stimulation. An updated review of the literature,” Frontiers in Physiolology, vol. 8, no. 258, pp. 1–16, 2017. View at Google Scholar
  9. A. Lubkowska, G. Banfi, B. Dolegowska, G. V. d’Eril, J. Łuczak, and A. Barrasi, “Changes in lipid profile in response to three different protocols of whole-body cryostimulation treatments,” Cryobiology, vol. 61, no. 1, pp. 22–26, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Lubkowska, W. Dudzińska, I. Bryczkowska, and B. Dołęgowska, “Body composition, lipid profile, adipokine concentration, and antioxidant capacity changes during interventions to treat overweight with exercise programme and whole-body cryostimulation,” Oxidative Medicine and Cellular Longevity, vol. 2015, Article ID 803197, 13 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Rymaszewska, D. Ramsey, and S. Chładzińska-Kiejna, “Whole-body cryotherapy as adjunct treatment of depressive and anxiety disorders,” Archivum Immunologiae et Therapiae Experimentalis, vol. 56, no. 1, pp. 63–68, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. E. Miller, M. Mrowiecka, K. Malinowska, K. Zołynski, and J. Kedziora, “Effects of the whole-body cryotherapy on a total antioxidative status and activities of some antioxidative enzymes in blood of patients with multiple sclerosis-preliminary study,” The Journal of Medical Investigation, vol. 57, no. 1,2, pp. 168–173, 2010. View at Publisher · View at Google Scholar
  13. H. Hirvonen, H. Kautiainen, E. Moilanen, M. Mikkelsson, and M. Leirisalo-Repo, “The effect of cryotherapy on total antioxidative capacity in patients with active seropositive rheumatoid arthritis,” Rheumatology International, vol. 37, no. 9, pp. 1481–1487, 2017. View at Publisher · View at Google Scholar
  14. L. Jagodziński, A. Stanek, J. Gmyrek, G. Cieślar, A. Sielańczyk, and A. Sieroń, “Evaluation of whole-body cryotherapy on the circulatory system in patients with ankylosing spondylitis by analysis of duration and QT interval dispersion,” Polish Journal of Physiotherapy, vol. 7, no. 3, pp. 362–369, 2007. View at Google Scholar
  15. A. Stanek, A. Cholewka, J. Gaduła, Z. Drzazga, A. Sieroń, and K. Sieroń-Stołtny, “Can whole-body cryotherapy with subsequent kinesiotherapy procedures in closed type cryogenic chamber improve BASDAI, BASFI, some spine mobility parameters and decrease pain intensity in patients with ankylosing spondylitis?” BioMed Research International, vol. 2015, Article ID 404259, 11 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  16. M. W. Romanowski, W. Romanowski, P. Keczmer, M. Majchrzycki, W. Samborski, and A. Straburzynska-Lupa, “Whole body cryotherapy in rehabilitation of patients with ankylosing spondylitis. A randomised controlled study,” Physiotherapy, vol. 101, article e1294, Supplement 1, 2015. View at Publisher · View at Google Scholar
  17. A. Stanek, G. Cieślar, K. Strzelczyk et al., “Influence of cryogenic temperatures on inflammatory markers in patients with ankylosing spondylitis,” Polish Journal of Environmental Study, vol. 19, no. 1, pp. 167–175, 2010. View at Google Scholar
  18. S. van der Linden, H. A. Valkenburg, and A. Catts, “Evaluation of diagnostic criteria for ankylosing spondylitis,” Arthritis & Rheumatology, vol. 27, no. 4, pp. 361–368, 1984. View at Publisher · View at Google Scholar · View at Scopus
  19. R. Richterich, Clinical Chemistry: Theory and Practice, Academic Press, New York, 1969.
  20. H. Ohkawa, N. Ohishi, and K. Yagi, “Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction,” Analytical Biochemistry, vol. 95, no. 2, pp. 351–358, 1979. View at Publisher · View at Google Scholar · View at Scopus
  21. O. Erel, “A new automated colorimetric method for measuring total oxidant status,” Clinical Biochemistry, vol. 38, no. 12, pp. 1103–1111, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Harma, M. Harma, and O. Erel, “Increased oxidative stress in patients with hydatidiform mole,” Swiss Medical Weekly, vol. 133, no. 41-42, pp. 563–566, 2003. View at Google Scholar
  23. Y. Oyanagui, “Reevaluation of assay methods and establishment of kit for superoxide dismutase activity,” Analytical Biochemistry, vol. 142, no. 2, pp. 290–296, 1984. View at Publisher · View at Google Scholar · View at Scopus
  24. H. Aebi, “[13] Catalase in vitro,” Methods in Enzymology, vol. 105, pp. 121–126, 1984. View at Publisher · View at Google Scholar · View at Scopus
  25. D. Paglia and W. Valentine, “Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase,” The Journal of Laboratory and Clinical Medicine, vol. 70, no. 1, pp. 158–169, 1967. View at Google Scholar
  26. I. F. F. Benzie and J. J. Strain, “The ferric reducing ability of plasma (FRAP) as a measure of “antioxidant power: the FRAP assay”,” Analytical Biochemistry, vol. 239, no. 1, pp. 70–76, 1996. View at Publisher · View at Google Scholar · View at Scopus
  27. J. F. Koster, P. Biemond, and A. J. Swaak, “Intracellular and extracellular sulphydryl levels in rheumatoid arthritis,” Annals of the Rheumatic Diseases, vol. 45, no. 1, pp. 44–46, 1986. View at Publisher · View at Google Scholar
  28. Y. Zhao, X. Yang, W. Lu, H. Liao, and F. Liao, “Uricase based methods for determination of uric acid in serum,” Microchimica Acta, vol. 164, no. 1-2, pp. 1–6, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. S. Garrett, T. Jenkinson, L. G. Kennedy, H. Whitelock, P. Gaisford, and A. Calin, “A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index,” Journal of Rheumatology, vol. 21, no. 12, pp. 2286–2291, 1994. View at Google Scholar
  30. A. Calin, S. Garrett, H. Whitelock et al., “A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index,” The Journal of Rheumatology, vol. 21, no. 12, pp. 2281–2285, 1984. View at Google Scholar
  31. E. Ziemann, R. A. Olek, S. Kujach et al., “Five-day whole-body cryostimulation, blood inflammatory markers, and performance in high-ranking professional tennis players,” Journal of Athletic Training, vol. 47, no. 6, pp. 664–672, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. G. Banfi, M. Melegati, A. Barassi et al., “Effects of whole-body cryotherapy on serum mediators of inflammation and serum muscle enzymes in athletes,” Journal of Thermal Biology, vol. 34, no. 2, pp. 55–59, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. H. Pournot, F. Bieuzen, J. Louis et al., “Time-course of changes in inflammatory response after whole-body cryotherapy multi exposures following severe exercise,” PLoS One, vol. 6, no. 7, article e22748, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. B. Dugué, J. Smolander, T. Westerlund et al., “Acute and long-term effects of winter swimming and whole-body cryotherapy on plasma antioxidative capacity in healthy women,” Scandinavian Journal of Clinical and Laboratory Investigation, vol. 65, no. 5, pp. 395–402, 2005. View at Publisher · View at Google Scholar · View at Scopus
  35. A. Stanek, K. Sieroń-Stołtny, E. Romuk et al., “Whole-body cryostimulation as an effective method of reducing oxidative stress in healthy men,” Advances in Clinical and Experimental Medicine, vol. 25, no. 6, pp. 1281–1291, 2016. View at Publisher · View at Google Scholar · View at Scopus
  36. B. Skrzep-Poloczek, E. Romuk, and E. Birkner, “The effect of whole-body cryotherapy on lipids parameters in experimental rat model,” Polish Journal of Balneology, vol. 44, no. 1–4, pp. 7–13, 2002. View at Google Scholar